Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Eclipse Treatment Planning System (v18.0)

K-Number: K230557 · 2023-05-26

Decision Date2023-05-26
Product CodeMUJ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Eclipse Treatment Planning System (v18.0) is a medical device manufactured by Varian Medical Systems, Inc.. It received FDA 510(k) clearance on 2023-05-26 under approval number K230557. The device is classified under product code MUJ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Eclipse Treatment Planning System (v18.0)?

Eclipse Treatment Planning System (v18.0) is a medical device that received FDA 510(k) clearance on 2023-05-26. It is manufactured by Varian Medical Systems, Inc.. The 510(k) number is K230557.

When was Eclipse Treatment Planning System (v18.0) approved by the FDA?

Eclipse Treatment Planning System (v18.0) received FDA 510(k) clearance on 2023-05-26, under approval number K230557.

What company makes Eclipse Treatment Planning System (v18.0)?

Eclipse Treatment Planning System (v18.0) is manufactured by Varian Medical Systems, Inc..

What is the FDA product code for Eclipse Treatment Planning System (v18.0)?

The FDA product code for Eclipse Treatment Planning System (v18.0) is MUJ.

Related Clinical Trials

Related PubMed Literature

Other Devices by Varian Medical Systems, Inc.

View all 83 devices →

Related Devices (Code: MUJ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.